Prostate cancer discovery enabled by Biolog technology
May 16, 2018 07:45 ET
|
Biolog, Inc.
HAYWARD, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- A discovery made using Phenotype MicroArray™ technology has led to a deeper understanding of the lethal role of the PTEN null mutation in prostate...
Biolog GEN III Technology Proves Its Accuracy in the First Direct Comparison Against Molecular Methods
August 07, 2014 13:30 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwired - Aug 7, 2014) - In a paper published in the Journal of Microbiological Methods (on-line July 9, in print in October) scientists from the Animal Health Veterinary...
Biolog Announces Appointment of Distributors in Europe
March 29, 2012 07:45 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwire - Mar 29, 2012) - New distributors were announced today by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification...
Anti-Cancer Drug Sensitivity Changes Detected With Biolog Phenotype MicroArrays
April 08, 2011 00:01 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwire - Apr 8, 2011) - Biolog, Inc. reported today that two recent scientific presentations have demonstrated the usefulness of Biolog's Phenotype MicroArray™ technology for...
Differentiation and Mutation Changes in Mammalian Cells of Shared Lineage Determined With Assay Method That Measures Multiple Energy-Producing Pathways
March 24, 2011 17:30 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwire - March 24, 2011) - In a paper published today in the journal PLoS ONE, researchers from Biolog, Inc., and the Broad Institute of Harvard & MIT describe the...
Fungal Toxin Mystery Solved Using Biolog's Phenotype MicroArray(TM) Technology
June 18, 2009 07:45 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwire - June 18, 2009) - An important breakthrough in fungal toxin
biology has been made possible through the use of Biolog's Phenotype
MicroArray technology. This major advance...